Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

Similar articles for PubMed (Select 17646646)

1.

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.

Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12867-72. Epub 2007 Jul 23.

2.

Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.

Shen Y, Li J, Nitta M, Futalan D, Steed T, Treiber JM, Taich Z, Stevens D, Wykosky J, Chen HZ, Carter BS, Becher OJ, Kennedy R, Esashi F, Sarkaria JN, Furnari FB, Cavenee WK, Desai A, Chen CC.

Oncotarget. 2015 May 20;6(14):11751-67.

3.

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

Zahonero C, Aguilera P, Ramírez-Castillejo C, Pajares M, Bolós MV, Cantero D, Perez-Nuñez A, Hernández-Laín A, Sánchez-Gómez P, Sepúlveda JM.

Mol Cancer Ther. 2015 May 4. [Epub ahead of print]

PMID:
25939761
4.

Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.

Walsh AM, Kapoor GS, Buonato JM, Mathew LK, Bi Y, Davuluri RV, Martinez-Lage M, Simon MC, O'Rourke DM, Lazzara MJ.

Mol Cancer Res. 2015 May 1. pii: molcanres.0183.2014. [Epub ahead of print]

PMID:
25934697
5.

AMG 595, an Anti-EGFRvIII Antibody-Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma.

Hamblett KJ, Kozlosky CJ, Siu S, Chang WS, Liu H, Foltz IN, Trueblood ES, Meininger D, Arora T, Twomey B, Vonderfecht SL, Chen Q, Hill JS, Fanslow WC.

Mol Cancer Ther. 2015 Apr 30. [Epub ahead of print]

PMID:
25931519
6.

Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Gilder AS, Jones KA, Hu J, Wang L, Chen CC, Carter BS, Gonias SL.

J Biol Chem. 2015 Jun 12;290(24):14798-809. doi: 10.1074/jbc.M115.637488. Epub 2015 Apr 2.

PMID:
25837250
7.

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.

van den Bent MJ, Gao Y, Kerkhof M, Kros JM, Gorlia T, van Zwieten K, Prince J, van Duinen S, Sillevis Smitt PA, Taphoorn M, French PJ.

Neuro Oncol. 2015 Jul;17(7):935-41. doi: 10.1093/neuonc/nov013. Epub 2015 Feb 16.

PMID:
25691693
8.

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma.

Padfield E, Ellis HP, Kurian KM.

Front Oncol. 2015 Jan 29;5:5. doi: 10.3389/fonc.2015.00005. eCollection 2015. Review.

9.

EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications.

Greenall SA, Donoghue JF, Van Sinderen M, Dubljevic V, Budiman S, Devlin M, Street I, Adams TE, Johns TG.

Oncogene. 2015 Feb 9. doi: 10.1038/onc.2014.448. [Epub ahead of print]

PMID:
25659577
10.

Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1.

Kim EJ, Kim SO, Jin X, Ham SW, Kim J, Park JB, Lee JY, Kim SC, Kim H.

Tumour Biol. 2015 Apr;36(4):2921-8. doi: 10.1007/s13277-014-2922-9. Epub 2014 Dec 17.

PMID:
25514871
11.

A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.

Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB.

Cancer Res. 2015 Jan 15;75(2):394-404. doi: 10.1158/0008-5472.CAN-14-2004. Epub 2014 Nov 28.

PMID:
25432173
12.

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.

Hu J, Muller KA, Furnari FB, Cavenee WK, VandenBerg SR, Gonias SL.

Oncogene. 2014 Oct 27. doi: 10.1038/onc.2014.336. [Epub ahead of print]

PMID:
25347738
13.

Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies.

Roth P, Weller M.

Neuro Oncol. 2014 Oct;16 Suppl 8:viii14-9. doi: 10.1093/neuonc/nou222.

PMID:
25342600
14.

RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma.

Yeom SY, Nam DH, Park C.

Mol Cancer Ther. 2014 Dec;13(12):3049-61. doi: 10.1158/1535-7163.MCT-14-0244. Epub 2014 Oct 13.

PMID:
25313011
15.

Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B.

Hamm R, Zeino M, Frewert S, Efferth T.

Toxicol Appl Pharmacol. 2014 Sep 11;281(1):78-86. doi: 10.1016/j.taap.2014.08.033. [Epub ahead of print]

PMID:
25218289
16.

EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers.

Faulkner C, Palmer A, Williams H, Wragg C, Haynes HR, White P, DeSouza RM, Williams M, Hopkins K, Kurian KM.

Br J Neurosurg. 2014 Aug 20:1-7. [Epub ahead of print]

PMID:
25141189
17.

Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells.

Munoz JL, Rodriguez-Cruz V, Greco SJ, Nagula V, Scotto KW, Rameshwar P.

Mol Cancer Ther. 2014 Oct;13(10):2399-411. doi: 10.1158/1535-7163.MCT-14-0011. Epub 2014 Jul 22.

PMID:
25053824
18.

Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.

Sangar V, Funk CC, Kusebauch U, Campbell DS, Moritz RL, Price ND.

Mol Cell Proteomics. 2014 Oct;13(10):2618-31. doi: 10.1074/mcp.M114.040428. Epub 2014 Jul 5.

PMID:
24997998
19.

Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells.

Furcht CM, Buonato JM, Skuli N, Mathew LK, Muñoz Rojas AR, Simon MC, Lazzara MJ.

J Cell Sci. 2014 Aug 15;127(Pt 16):3555-67. doi: 10.1242/jcs.150862. Epub 2014 Jun 20.

20.

A U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.

Zhang X, Liang H, Tan Y, Wu X, Li S, Shi Y.

Biomed Rep. 2014 Jul;2(4):495-499. Epub 2014 May 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk